Skip to main content
. Author manuscript; available in PMC: 2023 Mar 24.
Published in final edited form as: Neuroimage Rep. 2021 Mar 4;1(1):100005. doi: 10.1016/j.ynirp.2021.100005

Table:

Demographics, clinical measures, and motion parametersa

FEP (n= 78) HC (n= 64) t/X2/F p value
Demographic variables
 Gender (% male) 64.1 64.1 0.00 1.0
 Age 23.71 (5.96) 24.27 (5.87) 0.56 .58
 Parental Occupationb 5.46 (4.62) 4.23 (3.99) 16.27 .43
Clinical variables
 Diagnosis
  Schizophrenia 41
  Schizoaffective Disorder 15
  Schizophreniform Disorder 3
  Brief Psychotic Disorder 2
  Bipolar Disorder with psychosis 3
  Major Depression with psychosis 2
  Unspecified Psychosis 12
 Duration of untreated psychosis [in months; median, mean, (SD)]c 7; 23.50 (40.59)
 UDS +cannabis (%) 32.1
 BPRSd
   Total 49.75 (11.47)
   Positive 15.62 (4.10)
   Negative 5.71 (3.10)
 RBANSe
  Total index 73.49 (15.21) 92.47 (10.96) 8.11 < .01
  Immediate memory 80.94 (16.68) 101.05 (15.99) 6.87 < .01
  Visuospatial 74.25 (11.62) 82.33 (13.02) 2.95 < .01
  Language 80.94 (16.68) 97.50 (14.91) 4.84 < .01
  Attention span 79.81 (16.72) 101.57 (15.95) 7.43 < .01
  Delayed memory 76.25 (15.69) 90.98 (8.78) 6.62 < .01
Scan quality data
 DWIf
  RMS absolute motion (mm) 0.39 (0.24) 0.32 (0.20) −1.90 .06
  RMS relative motion (mm) 0.007 (0.006) 0.005 (0.004) −1.62 .10

FEP, first episode psychosis patient; HC, healthy control; UDS, urine drug screen; DWI, diffusion weighted image; DWI, diffusion weighted imaging; RMS, root mean square of the six motion parameters (translations and rotations)

a

Mean (SD) unless indicated otherwise

b

Ranks determined from Diagnostic Interview for Genetic Studies (1 – 18 scale); higher rank (lower numerical value) corresponds to higher socioeconomic status

c

data not available for one subject

d

Brief Psychiatric Rating Scale (1 – 7 scale); positive (conceptual disorganization, hallucinatory behavior, suspiciousness and unusual thought content); negative (emotional withdrawal, motor retardation, and blunted affect); data available for 77 patients

e

Repeatable Battery for the Assessment of Neuropsychological Status; data available for 58 HC and 68 FEP

f

data available for 59 HC and 61 FEP